Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial-Reference-Cited by-同舟云学术

Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial

Published:2014-03 Issue:3 Volume:15 Page:286-296
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Motzer Robert J,Porta Camillo,Vogelzang Nicholas J,Sternberg Cora N,Szczylik Cezary,Zolnierek Jakub,Kollmannsberger Christian,Rha Sun Young,Bjarnason Georg A,Melichar Bohuslav,De Giorgi Ugo,Grünwald Viktor,Davis Ian D,Lee Jae-Lyun,Esteban Emilio,Urbanowitz Gladys,Cai Can,Squires Matthew,Marker Mahtab,Shi Michael M,Escudier Bernard

Publisher

Elsevier BV

Subject

Oncology

Reference31 articles.

1. Treatment selection in metastatic renal cell carcinoma: expert consensus;Escudier;Nat Rev Clin Oncol,2012

2. Temsirolimus: a safety and efficacy review;Bukowski;Expert Opin Drug Saf,2012

3. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis;Presta;Cytokine Growth Factor Rev,2005

4. Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?;Granato;Breast Cancer Res,2004

Cited by 243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in the small-molecule drugs for hepatocellular carcinoma (HCC): Structure-activity relationships, pharmacological activities, and the clinical trials;Biomedicine & Pharmacotherapy;2024-10

2. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14

3. Small Molecules That Degrade RNA;Methods and Principles in Medicinal Chemistry;2024-07-05

4. Final Analysis of a Noninterventional Study on Cabozantinib in Patients With Advanced Renal Cell Carcinoma After Prior Checkpoint Inhibitor Therapy of the German Interdisciplinary Working Group on Renal Tumors (IAG-N);Clinical Genitourinary Cancer;2024-07

5. HMGA1 sensitizes esophageal squamous cell carcinoma to mTOR inhibitors through the ETS1-FKBP12 axis;International Journal of Biological Sciences;2024